Fludase - Experimental Antiviral Drug for Influenza

 

Key Data:

Drug (brand/generic)
Fludase (DAS181)
Company/licensee
NexBio
Therapy class
Anti-viral agent
Product description
Recombinant sialidase fusion protein
Current indication
Treatment of influenza
Market sector
Anti-infectives
Development status
Phase I

Return to Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development